JAMMIPub Date : 2019-06-17eCollection Date: 2019-06-01DOI: 10.3138/jammi.2019.03.17.fr
{"title":"Énoncé de position de l'AMMI Canada sur le diagnostic de la maladie de Lyme et le traitement des personnes ayant des symptômes persistants attribués à cette maladie.","authors":"","doi":"10.3138/jammi.2019.03.17.fr","DOIUrl":"https://doi.org/10.3138/jammi.2019.03.17.fr","url":null,"abstract":"","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":"47-50"},"PeriodicalIF":0.0,"publicationDate":"2019-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602955/pdf/jammi.2019.03.17.fr.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40449598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMMIPub Date : 2019-06-17eCollection Date: 2019-06-01DOI: 10.3138/jammi.2019.02.08
Fred Y Aoki, Upton D Allen, Samira Mubareka, Jesse Papenburg, H Grant Stiver, Gerald A Evans
{"title":"Use of antiviral drugs for seasonal influenza: Foundation document for practitioners-Update 2019.","authors":"Fred Y Aoki, Upton D Allen, Samira Mubareka, Jesse Papenburg, H Grant Stiver, Gerald A Evans","doi":"10.3138/jammi.2019.02.08","DOIUrl":"10.3138/jammi.2019.02.08","url":null,"abstract":"<p><p>This document updates the previous AMMI Canada Foundation Guidance (2013) on the use of antiviral therapy for influenza.</p>","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":"60-82"},"PeriodicalIF":0.0,"publicationDate":"2019-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602959/pdf/jammi.2019.02.08.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40447224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMMIPub Date : 2019-06-17eCollection Date: 2019-06-01DOI: 10.3138/jammi.2018-0043
Salem Agabawi, Vanessa Tran, James McEachern, Andrew Walkty
{"title":"Gonococcal meningitis: An unusual presentation of disseminated gonococcal infection.","authors":"Salem Agabawi, Vanessa Tran, James McEachern, Andrew Walkty","doi":"10.3138/jammi.2018-0043","DOIUrl":"https://doi.org/10.3138/jammi.2018-0043","url":null,"abstract":"<p><p>Gonorrhea is a sexually transmitted infection caused by <i>Neisseria gonorrhoeae</i>. The rate of <i>N. gonorrhoeae</i> infections in Canada has increased from 2010 to 2015. Disseminated gonococcal infection typically results from bacteremic spread of <i>N. gonorrhoeae</i> from a preceding mucosal site of disease (e.g., urogenital). Common clinical manifestations of disseminated gonococcal infection include skin lesions, tenosynovitis, and septic arthritis. Bacterial meningitis as a manifestation of disseminated gonococcal infection has been rarely described. A case of bacterial meningitis due to <i>N. gonorrheae</i>, complicated by an ischemic stroke, is reported here. Clinical features that may point to <i>N. gonorrhoeae</i> as the pathogen in a patient with bacterial meningitis include a concomitant active urogenital infection, skin rash, arthritis, and/or tenosynovitis. Parenteral ceftriaxone for 10 to 14 days combined with a single oral dose of azithromycin is currently recommended as the treatment for gonococcal meningitis in recent guidelines. This case is presented to highlight a potential, albeit rare, complication of a preventable disease that has resurged in the last decade in our community.</p>","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":"116-120"},"PeriodicalIF":0.0,"publicationDate":"2019-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3138/jammi.2018-0043","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40447217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMMIPub Date : 2019-06-17eCollection Date: 2019-06-01DOI: 10.3138/jammi.2018-0039
Daniel L Landry, Sherif Eltonsy, Luc P Jalbert, Gabriel Girouard, Jonathan Couture, Mathieu Bélanger
{"title":"Continuous cefazolin infusion versus cefazolin plus probenecid for the ambulatory treatment of uncomplicated cellulitis: A retrospective cohort study.","authors":"Daniel L Landry, Sherif Eltonsy, Luc P Jalbert, Gabriel Girouard, Jonathan Couture, Mathieu Bélanger","doi":"10.3138/jammi.2018-0039","DOIUrl":"https://doi.org/10.3138/jammi.2018-0039","url":null,"abstract":"<p><strong>Background: </strong>The preferred ambulatory IV therapy for cellulitis is often once-daily cefazolin combined with once-daily oral probenecid (C+P). However, due to a national probenecid drug shortage in 2011, our centre developed a replacement protocol for the administration of cefazolin continuous infusion (CCI) using elastomeric infusers. Our goal was to compare treatment efficacy, duration of IV therapy, and recurrence associated with CCI and C+P using retrospective data from our centre.</p><p><strong>Methods: </strong>We conducted a non-inferiority single-centre retrospective cohort study of emergency department medical records. Patients received either C+P (cefazolin 2 g IV once daily plus probenecid 1 g PO once daily) or CCI (cefazolin 2 g IV loading dose, followed by cefazolin 6 g IV via continuous infusion over 24 hours, via an elastomeric infuser). We compared treatment efficacy, duration of IV therapy, and recurrence rates.</p><p><strong>Results: </strong> total of 203 patients were analyzed, with 107 included in the CCI arm and 96 in the C+P arm. Overall, CCI users and C+P users were comparable in their sociodemographic and clinical variables measured at admission. We observed increased odds of achieving successful treatment among the CCI group, however it did not reach statistical significance (odds ratio [OR] 2.25; 95% CI 0.84 to 6.07). Recurrence rates were similar between both groups (OR 1.91; 95% CI 0.32 to 11.31). The average duration of IV therapy was similar between groups (<i>p</i> = 0.6).</p><p><strong>Conclusions: </strong>ith results suggesting that CCI was non-inferior to C+P, and that both approaches required similar treatment durations, CCI could represent an acceptable alternative to C+P for the ambulatory IV treatment of cellulitis.</p>","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":"108-112"},"PeriodicalIF":0.0,"publicationDate":"2019-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3138/jammi.2018-0039","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40447221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMMIPub Date : 2019-06-17eCollection Date: 2019-06-01DOI: 10.3138/jammi.2018-0041
Jean-Michel Leduc, Claude Fortin, Danielle Rouleau, Valérie Martel-Laferrière
{"title":"Measuring the impact of an HIV rotation on trainees' knowledge and confidence level: The importance of inviting recent graduates.","authors":"Jean-Michel Leduc, Claude Fortin, Danielle Rouleau, Valérie Martel-Laferrière","doi":"10.3138/jammi.2018-0041","DOIUrl":"https://doi.org/10.3138/jammi.2018-0041","url":null,"abstract":"<p><strong>Background: </strong>The new Canadian Residency Accreditation Consortium (CanRAC) standards recommend surveying recently graduated trainees to target improvements in training programs. The goal of this study was to estimate the impact of a rotation in an HIV clinic on trainees' related knowledge, confidence, and practice profile at the Université de Montréal.</p><p><strong>Methods: </strong>An electronic survey was sent to practising physicians who completed the rotation between 2006 and 2016. Participants were asked to rate their agreement and level of confidence toward HIV- and HCV-related topics using 5-point Likert scales (0 to 4). Descriptive statistics and mean comparisons were calculated.</p><p><strong>Results: </strong>Among invited participants, 27 of 45 (60%) completed the questionnaire. The majority of respondents were infectious diseases physicians (48%) or family physicians (37%) and had an outpatient caseload of <10 HIV patients/year (80%). For 37% of the respondents, the rotation had a large or very large impact on their career path. They considered that the rotation had increased their knowledge on the overall management of HIV (mean 3.2/4 [95% CI 2.9 to 3.4]), but less on pre-exposure prophylaxis (PrEP) (mean 1.5/4 [95% CI 1.1 to 2.0]) or HCV care (mean 1.9/4 [95% CI 1.4 to 2.3]). Participants felt less confident with genotyping interpretation (mean 2.6/4 [95% CI 2.2 to 2.9]) and PrEP (mean 2.4/4 [95% CI 2.0 to 2.8]).</p><p><strong>Conclusions: </strong>These results suggest that a rotation in an HIV clinic improves knowledge related to HIV care. Feedback from past graduates helped us identify gaps in knowledge or level of confidence in PrEP and HCV care, which will feed curriculum improvement.</p>","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":"83-89"},"PeriodicalIF":0.0,"publicationDate":"2019-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602958/pdf/jammi.2018-0041.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40447225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMMIPub Date : 2018-12-01DOI: 10.3138/JAMMI.2018-08.07.2
B. Chase, P. Bonnar
{"title":"A walk through the tall grass: A case of transaminitis, thrombocytopenia, and leukopenia resulting from an emerging zoonotic infection in Nova Scotia","authors":"B. Chase, P. Bonnar","doi":"10.3138/JAMMI.2018-08.07.2","DOIUrl":"https://doi.org/10.3138/JAMMI.2018-08.07.2","url":null,"abstract":"Tick born zoonotic infections spread by Ixodes scapularis are on the rise in Canada. Tick-borne illnesses have a large constellation of symptoms associated with them which can often overlap and cloud diagnostic certainty. Human granulocytic anaplasmosis (HGA) is an emerging infectious disease in Canada, with tick carriage rates as high as 15% in some parts of the country. The majority of cases are associated with fever, headache, myalgia and malaise, thrombocytopenia, and transaminitis. The diagnosis is made through indirect fluorescent antibody titres, examination of peripheral smear, or polymerase chain reaction. Here we present the case of an otherwise health 71-year-old male presenting with fevers, thrombocytopenia, leukopenia, and a mixed transaminitis following a tick bite. He was subsequently diagnosed as the first case of HGA in Nova Scotia confirmed by indirect fluorescent antibody titre.","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3138/JAMMI.2018-08.07.2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41590630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMMIPub Date : 2018-12-01DOI: 10.3138/JAMMI.2018-0023
Salem Agabawi, A. Walkty, B. Pilkey, Rick Bhullar, E. Trepman, J. Embil
{"title":"Tuberculosis of the foot mimicking Charcot arthropathy","authors":"Salem Agabawi, A. Walkty, B. Pilkey, Rick Bhullar, E. Trepman, J. Embil","doi":"10.3138/JAMMI.2018-0023","DOIUrl":"https://doi.org/10.3138/JAMMI.2018-0023","url":null,"abstract":"Mycobacterium tuberculosis bone and joint infection accounts for 2% to 3% of all tuberculosis cases but is uncommon in the foot. A 32-year-old woman had foot pain and swelling, and radiographs showed midfoot bony destruction and fragmentation. She was diagnosed with Charcot arthropathy, but had no neuropathy or improvement despite total contact casting. Bone biopsy 16 months after initial presentation did not show acid-fast bacilli on smear, but M. tuberculosis was recovered on culture; concurrent chest radiographs showed patchy and nodular opacities in both upper lung zones, consistent with previous pulmonary tuberculosis. Sputum smear showed acid-fast bacilli and culture yielded M. tuberculosis. In retrospect, the patient was at increased risk for M. tuberculosis infection because of previous residence in Myanmar and India. Clinicians should consider M. tuberculosis infection in the differential diagnosis of Charcot arthropathy for patients who have exposure history and absence of risk factors for Charcot arthropathy.","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3138/JAMMI.2018-0023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47301795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMMIPub Date : 2018-12-01DOI: 10.3138/JAMMI.2018-08.07.1
Michaeline McGuinty, C. Buchan
{"title":"Not so pretty in pink: A clinical vignette on invasive fungal sinusitis","authors":"Michaeline McGuinty, C. Buchan","doi":"10.3138/JAMMI.2018-08.07.1","DOIUrl":"https://doi.org/10.3138/JAMMI.2018-08.07.1","url":null,"abstract":"Invasive fungal infection is one of the most feared infectious complications in immunocompromised hosts following aggressive chemotherapy for hematologic malignancy and hematopoietic stem cell transplant (HSCT). The more common causes of sinusitis due to fungal pathogens (Mucorales, Fusarium, and Aspergillus spp) make up the majority of cases, but less common pathogens, including a number of dematiaceous fungi, can also be implicated. Early diagnosis is crucial; the mortality associated with fungal sinusitis is high and prompt, aggressive treatment is important for successful management. Prompt accurate microbiologic diagnosis is also crucial to direct effective treatment, especially in cases that do not respond to empiric therapy. Here we present an unusual case of invasive fungal sinusitis in a patient with relapsed refractory leukemia.","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3138/JAMMI.2018-08.07.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46435539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMMIPub Date : 2018-12-01DOI: 10.3138/JAMMI.2017-0009
Parmvir Parmar, C. Cooper
{"title":"Management of hepatitis C in a patient undergoing solid organ (kidney) transplant","authors":"Parmvir Parmar, C. Cooper","doi":"10.3138/JAMMI.2017-0009","DOIUrl":"https://doi.org/10.3138/JAMMI.2017-0009","url":null,"abstract":"Many patients with hepatitis C (HCV) suffer from concurrent renal disease requiring dialysis and eventual renal transplant. HCV treatment with direct-acting antivirals (DAA) is safe and effective in the context of renal transplant, but the optimal timing of treatment in proximity to transplant remains a focus of debate. We present the case of a 60-year-old male with HCV genotype 3 infection. He failed two prior interferon-based treatments, underwent previous separate liver and kidney transplants, and is currently under evaluation for a second kidney transplant for end-stage renal disease (ESRD). Using this illustrative case, we discuss topics pertinent to the evaluation and clinical care of HCV-infected renal transplant candidates including evaluation for a simultaneous liver-kidney transplant in the context of HCV infection, optimal timing of HCV treatment with respect to transplantation, and the safety and monitoring requirements during DAA treatment in renal transplant candidates.","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3138/JAMMI.2017-0009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46388150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMMIPub Date : 2018-12-01DOI: 10.3138/JAMMI.2018-0019
S. Herrera, Hussam Alobida, M. Bosaeed, S. Husain, C. Rotstein
{"title":"Increased incidence, risk factors, and outcomes of Trichosporon spp bloodstream infections in immunocompromised hosts","authors":"S. Herrera, Hussam Alobida, M. Bosaeed, S. Husain, C. Rotstein","doi":"10.3138/JAMMI.2018-0019","DOIUrl":"https://doi.org/10.3138/JAMMI.2018-0019","url":null,"abstract":"Objectives: To evaluate the incidence, risk factors, patient characteristics, and outcomes Trichosporon spp bloodstream infections in immunocompromised patients. Methods: This was a single centre retrospective study. Patients older than 18 years of age with Trichosporon spp bloodstream infections from 2004 to 2017 were reviewed. Data were extracted from the electronic medical records and the microbiology database and then analyzed. Results: Eight patients with Trichosporon spp bloodstream infections were included; 7 had hematological malignancies and 1 had ulcerative colitis but had undergone immunosuppressive therapy. A mean of 0.41 episodes per year were noted, but in 2017, 3 episodes were observed – more than a sevenfold increase over the mean. T. asahii was the most common isolate, seen in 7/9 isolates in 8 patients. Three episodes were labelled as primary fungemia (37.5%) and five (62.5%) were line-related. Previous use of steroids, broad-spectrum antibiotics, and neutropenia were found to be common co-existent factors in our patients. The mean treatment duration was 22.9 days and the response rate was 50% with a 30-day mortality rate of 50%. Conclusions: We observed a sixfold increase in the incidence of Trichosporon spp bloodstream infection in the final year of our study. These patients were predisposed to this infection due to their immunosuppressed state. Concerns about Trichosporon fungemia in such patients may impact the choice of antifungal therapy.","PeriodicalId":36782,"journal":{"name":"JAMMI","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3138/JAMMI.2018-0019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43907342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}